In this study, we demonstrated that baicalein exerted significant anti-inflammatory activity in TNBS-induced colitis in mice possibly via abrogating TLR4/myeloid differentiation factor 88 (MyD88) signaling pathway and its downstream signaling molecules, NF-κB and mitogen-activated protein kinases (MAPKs). Here, MYD88 is linked to colitis.